BAYERCROP

Bayer Cropscience Share Price

₹6,141.25
-174.1 (-2.76%)
13 November, 2024 13:46 BSE: 506285 NSE: BAYERCROP ISIN: INE462A01022

Start SIP in Bayer Cropscience

Start SIP

Bayer Cropscience Performance

Day Range

  • Low 6,102
  • High 6,349
₹ 6,141

52 Week Range

  • Low 4,901
  • High 7,197
₹ 6,141
  • Open Price6,282
  • Previous Close6,315
  • Volume12448

Bayer Cropscience Chart

  • Over 1 Month -8.33%
  • Over 3 Month -3.37%
  • Over 6 Month + 17.47%
  • Over 1 Year + 12.63%

Bayer Cropscience Key Statistics

P/E Ratio 41.4
PEG Ratio -2.8
Market Cap Cr 27,600
Price to Book Ratio 9.7
EPS 165.2
Dividend 2.3
Relative Strength Index 40.36
Money Flow Index 66.75
MACD Signal 21.36
Average True Range 191.17

Bayer Cropscience Investment Rating

  • Master Rating:
  • Bayer, a 160-year-old global life sciences company, has been a trusted brand in India for over 125 years, advancing agriculture, public health, and sustainability. Bayer’s operations in India include crop science, pharmaceuticals, and consumer health.

    Bayer Cropscience has an operating revenue of Rs. 4,994.80 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 18% is great, ROE of 25% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 12% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 42 which is a POOR score indicating inconsistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Chemicals-Agricultural and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Bayer Cropscience Financials
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,6317929551,6171,740983
Operating Expenses Qtr Cr 1,3176958271,3121,315777
Operating Profit Qtr Cr 31497128305425206
Depreciation Qtr Cr 221615123127
Interest Qtr Cr 453487
Tax Qtr Cr 62931837837
Net Profit Qtr Cr 2549693223329159
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 5,1845,204
Operating Expenses Annual Cr 4,1494,216
Operating Profit Annual in Cr 954924
Depreciation Cr 7480
Interest Annual Cr 2022
Tax Annual Cr 201232
Net Profit Annual Cr 741758
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 952609
Cash from Investing Activity Annual Cr 083
Cash from Financing Annual Activity Cr -656-613
Net Cash Flow Annual Cr 29679
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 2,8492,712
Fixed Assets Annual Cr 533572
Total Non Current Assets Annual Cr 692782
Total Current Assets Annual Cr 3,9063,896
Total Assets Annual Cr 4,5974,679
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 635604
ROE Annual % 2628
ROCE Annual % 3231
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2019
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Bayer Cropscience Technicals

EMA & SMA

Current Price
₹6,141.25
-174.1 (-2.76%)
pointer
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • ₹6,537.64
  • 50 Day
  • ₹6,503.54
  • 100 Day
  • ₹6,381.16
  • 200 Day
  • ₹6,098.46
  • 20 Day
  • ₹6,542.40
  • 50 Day
  • ₹6,497.72
  • 100 Day
  • ₹6,524.66
  • 200 Day
  • ₹6,044.46

Bayer Cropscience Resistance and Support

PIVOT
₹6,353.12
Resistance
First Resistance 6,411.23
Second Resistance 6,507.12
Third Resistance 6,565.23
RSI 40.36
MFI 66.75
MACD Single Line 21.36
MACD -1.45
Support
First Support 6,257.23
Second Support 6,199.12
Third Supoort 6,103.23

Bayer Cropscience Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 10,339 371,687 35.95
Week 13,653 540,916 39.62
1 Month 25,913 1,400,336 54.04
6 Month 46,390 3,032,967 65.38

Bayer Cropscience Result Highlights

Bayer Cropscience Synopsis

NSE-Chemicals-Agricultural

Bayer, a global leader in life sciences with over 160 years of expertise, has been a trusted presence in India since 1896. With more than 13,000 employees across the country, Bayer's operations span agriculture, healthcare, and consumer health, contributing to the nation's sustainability and self-reliance. Bayer CropScience Limited, the flagship company in India, is a key player in crop protection, offering innovative products and services. The company operates 7 manufacturing sites, 4 R&D units, and 2 centers of excellence in IT and finance. Bayer's mission, "Health for All, Hunger for None," reflects its commitment to global and local impact.
Market Cap 29,646
Sales 4,995
Shares in Float 1.30
No of funds 200
Yield 2.12
Book Value 10.39
U/D Vol ratio 1.4
LTDebt / Equity
Alpha 0.03
Beta 0.52

Bayer Cropscience Shareholding Pattern

Owner NameSep-24Jun-24Mar-24Dec-23
Promoters 71.43%71.43%71.43%71.43%
Mutual Funds 9.06%9.61%9.61%9.14%
Insurance Companies 2.53%2.78%3.15%3.52%
Foreign Portfolio Investors 3.3%3.63%3.62%3.53%
Financial Institutions/ Banks 0.02%0.02%0.02%0.02%
Individual Investors 8.57%7.96%7.74%7.84%
Others 5.09%4.57%4.43%4.52%

Bayer Cropscience Management

Name Designation
Mr. Pankaj Ramanbhai Patel Chairman & Ind.Dire (Non-Exe)
Mr. Simon Thorsten Wiebusch Vice Chairman & Mng.Director
Ms. Ketaki Sanat Bhagwati Ind. Non-Executive Director
Mr. Sekhar Natarajan Ind. Non-Executive Director
Mr. Simon Johannes Britsch Executive Director & CFO
Dr. Thomas Hoffmann Non Exe.Non Ind.Director
Dr. Miriam Holstein Non Exe.Non Ind.Director
Ms. Radhika Rajan Ind. Non-Executive Director

Bayer Cropscience Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bayer Cropscience Corporate Action

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-08 Quarterly Results
2024-05-23 Audited Results & Final Dividend
2024-02-01 Quarterly Results
2023-11-03 Quarterly Results & Interim Dividend
Date Purpose Remarks
2023-11-16 INTERIM Rs.105.00 per share(1050%)Interim Dividend
2022-11-19 INTERIM Rs.100.00 per share(1000%)Interim Dividend
2021-11-13 SPECIAL Rs.125.00 per share(1250%)Special Dividend

Bayer Cropscience FAQs

What is Share Price of Bayer Cropscience ?

Bayer Cropscience share price is ₹6,141 As on 13 November, 2024 | 13:32

What is the Market Cap of Bayer Cropscience ?

The Market Cap of Bayer Cropscience is ₹27600.1 Cr As on 13 November, 2024 | 13:32

What is the P/E ratio of Bayer Cropscience ?

The P/E ratio of Bayer Cropscience is 41.4 As on 13 November, 2024 | 13:32

What is the PB ratio of Bayer Cropscience ?

The PB ratio of Bayer Cropscience is 9.7 As on 13 November, 2024 | 13:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23